Floatz logo

Bazedoxifene

Postmenopausal Symptoms

Tulane University Health Sciences CenterSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Postmenopausal Symptoms cohort.

Asset / SponsorPhaseRating
17-beta-estradiol
Beijing Tiantan Hospital
Phase 4BBB
ESTROGENS, CONJUGATED
Tulane University Health Sciences Center
Phase 4BB
Prometrium
Beijing Tiantan Hospital
Phase 2CCC
Mecamylamine
University of Vermont
Early Phase 1CC

Same molecule, other indications

Bazedoxifene is also rated in:

Glucose HomeostasisDormant
BB
Indicative ·
69 / 100
View asset →
schizophreniform disorderDormant
BB
Indicative ·
65 / 100
View asset →
schizoaffective disorderDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →